Sol has founded three public companies (CTAI now EMIS, PDC now MNKD, & BIOD) and two private companies, Perosphere Pharmaceuticals, (sold to AMAG for $615 million in aggregate) and Perosphere Technologies. He invented AMAG’s rescue drug, ciraparantag, Biodel’s Ultra-rapid insulin, MannKind’s Afrezza & MedTone Inhaler.
President and Chief Executive Officer
Stephen is a seasoned healthcare entrepreneur with years of medical device and biopharmaceutical development and approvals experience, as well as successful IPO’s and exits including MNKD, PIX, and CTMX.
Andreas is a physician and chemist with 28 years of clinical expertise in diabetes, endocrinology and AIDS. He is also a Professor of Internal Medicine and Laboratory Medicine at the University for Digital Technologies in Medicine & Dentistry, Wiltz, Luxembourg and, since 2013, has been the CEO of Pfützner Science & Health Institute.
Daniel is an entrepreneur and CEO of Zedsen, one of the fastest growing startups in the UK. Their unique sensors allow for breakthrough applications for the non-invasive monitoring of glucose and other biometric parameters. Daniel has led the company from its inception through seed, series A and series B funding to present.